Platform
Company
Complete Blood Count
Review status
Currently under review
Pending specialist review and validation.
Mean cell hemoglobin (MCH) tells you the average amount of hemoglobin contained in each red blood cell. Hemoglobin is the protein that carries oxygen to your baby’s tissues. This test is part of the complete blood count and helps describe the size and hemoglobin content of red blood cells.
When measured on a cord blood sample collected at delivery, MCH reflects your newborn’s blood at birth. Cord blood testing provides a snapshot of red blood cell characteristics during the transition from life in the womb to life outside, when patterns of red blood cell production and hemoglobin types are changing.
MCH can help your baby’s care team evaluate anemia and understand whether red blood cells are producing and carrying hemoglobin as expected. It is interpreted together with other red cell indices, such as mean cell volume and mean cell hemoglobin concentration, as well as the hemoglobin and hematocrit.
Doctors may request MCH on cord blood as part of routine newborn labs or when there are concerns such as pallor, jaundice, feeding difficulties, or a history that suggests iron, folate, or vitamin B12 issues. The test uses blood from the umbilical cord, so it does not require a separate needle stick for your baby.
A higher MCH suggests red blood cells contain more hemoglobin than usual, which can occur when cells are larger or younger, or when there is a problem with DNA synthesis. A lower MCH suggests reduced hemoglobin content per cell, which can be seen with iron restriction or some inherited conditions that affect hemoglobin production.
Because newborn red blood cells and hemoglobin types differ from those of older children and adults, results are compared with newborn cord blood reference ranges. Your baby’s clinician will consider the full blood count, birth history, and physical exam before deciding on next steps. If results are outside the expected range or your baby has symptoms, follow-up may include repeating the blood count after birth, checking iron studies, vitamin levels, or performing tests for inherited hemoglobin disorders. Most minor deviations can be monitored and discussed at routine pediatric visits.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Clotting in the tube, inadequate mixing with the anticoagulant, or prolonged time before analysis can distort cell measurements and lead to misleading MCH results.
Breakdown of red blood cells during collection or contamination with intravenous fluids can alter cell counts and calculated indices, potentially affecting the reported MCH.
Preterm birth and the timing of cord clamping influence newborn blood characteristics and volume, which can shift red cell indices and should be considered when interpreting MCH.
Maternal iron, folate, and vitamin B12 status, as well as prenatal supplementation, can affect fetal hemoglobin production and may influence the baby’s MCH at birth.
Conditions such as thalassemia traits or other hemoglobinopathies can change hemoglobin production and red blood cell indices, leading to a low or high MCH pattern.
Intrauterine transfusions, significant fetomaternal hemorrhage, or twin-to-twin transfusion can alter red blood cell populations and impact the MCH measurement.
References